Protocol for mild/moderate illness

Consent Forms

• Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma ThErapy - Consent Form (Kaufman, Approved)
• The suggested addendum addendum to standard institutional blood transfusion consent.

Protocols

• Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized patients (Pirofski, Approved) 
• Convalescent Plasma vs. Standard Plasma for COVID-19 (Bennett-Guerrero, Approved) 
• Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients (Ortigoza, Approved) 
• Passive Immunity Trial of Nashville II for COVID-19 (Rice, Approved) 
• Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma ThErapy (Kaufman, Approved)